Jan Pinkas - 07 Jul 2025 Form 3 Insider Report for CRESCENT BIOPHARMA, INC. (GLYC)

Signature
/s/ Barbara Bispham, as attorney-in-fact for Jan Pinkas
Issuer symbol
GLYC
Transactions as of
07 Jul 2025
Net transactions value
$0
Form type
3
Filing time
15 Jul 2025, 16:16:24 UTC
Next filing
16 Jul 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pinkas Jan Chief Scientific Officer C/O CRESCENT BIOPHARMA, INC., 300 FIFTH AVENUE, WALTHAM /s/ Barbara Bispham, as attorney-in-fact for Jan Pinkas 15 Jul 2025 0002077126

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney